Navigation Links
Sermo Report Indicates Possible Decline in Prescribing of Erythropoiesis-Stimulating Agents
Date:10/21/2010

litative Analysis

Physicians are required to complete the ESA REMS program by March 2011 to be eligible to prescribe these products. The goals of the REMS for ESAs are:

  • To support informed decisions between patients, their physicians, and other healthcare professionals by educating them on the risks of ESAs.
  • To mitigate the risk of decreased survival and/or poorer tumor outcomes in patients with cancer by implementing the part of the REMS called the ESA APPRISE Oncology Program.

Erythropoiesis Stimulating Agents include products from Amgen and Centocor Ortho Biotech Products, L.P.

To download report results, visit sermo.com/client.

About Sermo Reports

Sermo Reports solicit perceptions and opinions from physicians about new drugs, devices, treatments, and trends. Data for Sermo Reports is gathered through Sermo Posts, which allow physicians to participate in a poll and comment on the topic.  All physicians on Sermo are verified and credentialed.

About Sermo

Sermo is the largest online physician community, where over 115,000 practicing physicians discuss a wide range of issues from clinical cases to advice about drugs and practice management. By leveraging Sermo's social media platform, clients can tap into unsolicited, peer-to-peer dialog and engage MDs to gain market intelligence and increase brand awareness. For information, visit www.sermo.com/clients.


'/>"/>
SOURCE Sermo
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Sermo Announces New Client Center with Advanced Mining and Monitoring of Organic Physician Dialog
2. All-New Sermo Brings Major Enhancements to Nations Largest Online Physician Community
3. Sigma-Aldrich (Nasdaq: SIAL) Reports Q3 2010 Diluted EPS of $0.76. Diluted EPS Increased by 9% and 19% on a Reported and Adjusted Basis, Respectively. Q3 Sales Performance Remains Strong; Full Year 2010 Diluted Adjusted EPS Outlook Raised to $3.20 -
4. China Cord Blood Corporation Files Its Annual Report on Form 20-F/A
5. Reportlinker Adds Triple Analysis: Lymphoma, Cancer Vaccines and Antibodies
6. Reportlinker Adds BioMEMS 2010
7. Reportlinker Adds Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies
8. Reportlinker Adds Breast Cancer Drug Futures
9. Reportlinker Adds Industrial Biotechnology China News 1009
10. In-demand Contemporary Research Reports on Biotechnology Markets Available at MCGroup.co.uk
11. Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Arbor, Mich. Every day, their baby stopped breathing, ... to his lungs. April and Bryan Gionfriddo watched helplessly, ... , "Quite a few doctors said he had a ... April Gionfriddo, about her now 20-month-old son, Kaiba. "At ... we would take it and run with it." , ...
(Date:5/23/2013)... , May 23, 2013  BioScrip, Inc. (NASDAQ: ... present at the Jefferies 2013 Global Healthcare Conference to ... New York. Richard Smith ... Hai Tran , Chief Financial Officer, will present ... Daylight Time.   About BioScrip BioScrip, ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Graphite ... self-lubricating bushings mounted in stainless steel pillow ... properties of GRAPHALLOY with the application and installation ... Steel Pillow Blocks work exceptionally well when ... or hostile liquids such as acids, alkalies, hydrocarbons, ...
(Date:5/23/2013)... 2013 PuraMed BioScience ® , Inc., ... over-the-counter (OTC) medicinal and healthcare products, announced that ... company based on low market capitalization valuation. ... Natural Product to Treat Migraine Headaches , ... Competitor , Currently Available Nationwide at Walgreen,s ...
Breaking Biology Technology:Baby's life saved with groundbreaking 3-D printed device that restored his breathing 2Baby's life saved with groundbreaking 3-D printed device that restored his breathing 3Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 2Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 3PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3
... , , ... that it has entered into a cooperative research and development ... (NIAID), part of the National Institutes of Health (NIH), to ... mycobacteria (NTM) lung infections. , , Transave ...
... BEIJING, July 30 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, ... a growing developer and,producer of prescriptions drugs and ... Republic of China, today reported it received notice,of ... of the People,s,Republic of China for its innovative ...
... Dendreon Corporation (Nasdaq: DNDN ) management will host a conference call on ... quarter 2009 financial results. Access to the discussion may be obtained as follows: ... 11:30 AM ET /8:30 AM PT, Date: ... or +1-719-325-4873 (international), Webcast: www.dendreon.com (homepage and investor relations ...
Cached Biology Technology:Transave Enters Into Cooperative Research Agreement With NIH To Study ARIKACE(TM) In Nontuberculous Mycobacteria 2Transave Enters Into Cooperative Research Agreement With NIH To Study ARIKACE(TM) In Nontuberculous Mycobacteria 3Transave Enters Into Cooperative Research Agreement With NIH To Study ARIKACE(TM) In Nontuberculous Mycobacteria 4Lotus Pharmaceuticals, Inc. Announces Patent Pending Gliclazide-Controlled Release Tablets 2Lotus Pharmaceuticals, Inc. Announces Patent Pending Gliclazide-Controlled Release Tablets 3Dendreon to Hold Conference Call on Tuesday, August 11, 2009 at 11:30 AM ET 2
(Date:5/23/2013)... year, carrying more than 284 million tons of cargo, transit ... in toll fees for the Panama Canal Authority. Each time ... water are used from Gatun Lake, which is also a ... the isthmus. , However, the advent of very large ... ships at sea, has demanded change. The Panama Canal is ...
(Date:5/23/2013)... which estrogen suppresses lipid synthesis in the liver, UC ... treating certain liver diseases. , With this finding, ... long-held views in the field. Study results appear in ... Signaling . , "The dogma in the steroid receptor ... located in the nucleus respond to steroid hormones by ...
(Date:5/23/2013)... overall health, development, and academic success of children, ... that all students have opportunities to engage in ... or moderate-intensity physical activity, says a new report ... suggest that only about half of school-age children ... and development. The report recommends that most ...
Breaking Biology News(10 mins):Reforestation study shows trade-offs between water, carbon and timber 2Reforestation study shows trade-offs between water, carbon and timber 3UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2Schools should provide opportunities for 60 minutes of daily physical activity to all students 2Schools should provide opportunities for 60 minutes of daily physical activity to all students 3
... eyes are closed, the visual centers in our brain are ... in the last few years that the magnitude of sense-related ... is quite similar to that of one exposed to a ... of that activity, explaining why, even though our sense centers ...
... ESA is now gearing up to return to Russia to ... now envisaged for launch on 16 March 2009. This follows ... Rockot launcher that delayed the launch of GOCE by Eurockot ... has just arrived at the Plesetsk Cosmodrome in northern Russia ...
... at Albert Einstein College of Medicine of Yeshiva University have ... and causes disease. The study, published in ... ( PNAS ), may help scientists develop new therapies ... These fungal infections occur most commonly in those with compromised ...
Cached Biology News:Behind closed eyes 2March launch planned for ESA's gravity mission 2Scientists discover how deadly fungus protects itself 2
... A very potent Rnase free ... over a broad range of ... protein does not inhibit SP6, ... AMV and M-MLV reverse transcriptase ...
... kit, 110 to 220 V, enables ... doubles flow rates and valve capacity ... kit includes the Maximizer base unit, ... tubing kit, system cable 30, and ...
Mouse monoclonal antibody to QDPR - quinoid dihydropteridine reductase...
Mouse polyclonal antibody to QDPR - quinoid dihydropteridine reductase...
Biology Products: